Freedom from Price Gouging Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Oct 11, 2019)
Freedom from Price Gouging Act
This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under Medicare that cost $100 or more and for which the average manufacturer price increases faster than inflation.
What just happenedOct 14, 2019
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseOct 11, 2019
- Oct 14, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Oct 11, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Oct 11, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Oct 11, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Oct 11, 2019IntroReferralIntro-H
Introduced in House
- Oct 11, 2019IntroReferral1000
Introduced in House